Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
The natural course of clinically isolated syndrome in pediatric patients.
Targeting human oligodendrocyte progenitors for myelin repair.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.
The prospects of minocycline in multiple sclerosis.
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis.
The translational biology of remyelination: Past, present, and future.
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
Naltrexone prescribing information
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Multiple sclerosis and sexual dysfunction.
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
Reward responsiveness and fatigue in multiple sclerosis.
Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients.

Pages